Skip to main content
Cancer Science logoLink to Cancer Science
. 2012 Jun 14;103(8):1378–1390. doi: 10.1111/j.1349-7006.2012.02326.x

Differences and similarities between carbon nanotubes and asbestos fibers during mesothelial carcinogenesis: Shedding light on fiber entry mechanism

Hirotaka Nagai 1,2, Shinya Toyokuni 1,
PMCID: PMC7659359  PMID: 22568550

Abstract

The emergence of nanotechnology represents an important milestone, as it opens the way to a broad spectrum of applications for nanomaterials in the fields of engineering, industry and medicine. One example of nanomaterials that have the potential for widespread use is carbon nanotubes, which have a tubular structure made of graphene sheets. However, there have been concerns that they may pose a potential health risk due to their similarities to asbestos, namely their high biopersistence and needle‐like structure. We recently found that despite these similarities, carbon nanotubes and asbestos differ in certain aspects, such as their mechanism of entry into mesothelial cells. In the study, we showed that non‐functionalized, multi‐walled carbon nanotubes enter mesothelial cells by directly piercing through the cell membrane in a diameter‐ and rigidity‐dependent manner, whereas asbestos mainly enters these cells through the process of endocytosis, which is independent of fiber diameter. In this review, we discuss the key differences, as well as similarities, between asbestos fibers and carbon nanotubes. We also summarize previous reports regarding the mechanism of carbon nanotube entry into non‐phagocytic cells. As the entry of fibers into mesothelial cells is a crucial step in mesothelial carcinogenesis, we believe that a comprehensive study on the differences by which carbon nanotubes and asbestos fibers enter into non‐phagocytic cells will provide important clues for the safer manufacture of carbon nanotubes through strict regulation on fiber characteristics, such as diameter, surface properties, length and rigidity. (Cancer Sci, doi: 10.1111/j.1349‐7006.2012.02326.x, 2012)


Nanotechnology is an emerging technology with the potential to make our daily lives better, as long as we know how it works.1 Asbestos, a natural fibrous silicate mineral, was once hailed as a miraculous stone and used throughout the world during the 20th century; however, it is now referred to as a time bomb due to its carcinogenicity through inhalation.2 The mechanism of asbestos‐induced carcinogenesis is yet to be fully unraveled, but it is currently known that asbestos fibers' physical characteristics, especially high biopersistence and needle‐like structure, are among the crucial factors responsible for causing cancer.3, 4 Carbon nanotubes are a nanomaterial that was recently discovered, manufactured, and commercially distributed. These tube‐shaped, carbon nanomaterials have raised social concerns due to their strong resemblance to asbestos fibers, especially in regard to the two features mentioned above.

The toxicological similarity of carbon nanotubes and asbestos fibers was reported by Poland et al.5 They reported that long fibers, whether they are carbon nanotubes or asbestos fibers, evade complete phagocytosis by macrophages and cause inflammation. This failure in phagocytosis, termed frustrated phagocytosis, has gained attention as a potential mechanism to explain the inflammogenicity and carcinogenicity of fibers.6, 7, 8

However, despite their similarities in certain aspects, carbon nanotubes and asbestos fibers vary in many physicochemical features, including constituent element, weight, and surface property. Therefore, we believe that these two distinct types of fibers do not necessarily exert toxicological effects through the same mechanism. One key difference that distinguishes these two fibers might be the mechanism of fiber entry into mesothelial cells. Considering that fiber entry into mesothelial cells is a key step in carcinogenesis, the difference between nanotubes and asbestos may provide a clue to aid in the development of safer carbon nanotubes. Moreover, the elucidation of the mechanism by which nanotubes enter into cells is of great use in both toxicology and medical applications.9

In this review, to establish a difference between the toxicological paradigms of carbon nanotubes and asbestos fibers, we summarize the current understanding of the differences and similarities between these two fibrous materials, with an emphasis on the entry mechanism of carbon nanotubes and asbestos fibers into non‐phagocytic cells.

Overview of Asbestos‐Induced Carcinogenesis

Before describing the similarities and differences between carbon nanotubes and asbestos fibers, we briefly outline the mechanism of asbestos‐induced carcinogenesis. Asbestos fibers are inhaled and eventually reach the pulmonary alveoli. During this process, asbestos fibers come into contact with epithelial cells in the trachea, bronchus and alveoli, as well as alveolar macrophages, leading to epithelial cell injury and macrophage activation. Small particles are well phagocytosed by macrophages and are excreted from the respiratory system via the lymphatic system. However, other long or large fibers that evade phagocytosis are not cleared and stay inside the lung for a long period of time, leading to chronic inflammation. Fibers that remain in the lung can physically penetrate through alveolar epithelial cells and visceral mesothelial cells and reach the parietal mesothelial cells due to negative pressure in the pleural cavity. Donaldson et al. hypothesized that long fibers (length > ~15 μm) tend to be trapped around the parietal stomata and the entryways to lymphatic vessels, as they cannot flow into the small openings like short fibers. Furthermore, they argued that mesothelial cell injury and macrophage activation occur at these sites of fiber accumulation, which then lead to the formation of mesothelioma.3

To date, we have four main criteria to assess toxicological and carcinogenic features of fibers: (i) translocation of fibers, such as from trachea to alveoli and from alveoli to parietal pleura; (ii) biopersistence, which determines the longevity of fibers inside organisms; (iii) mesothelial or epithelial cell injury caused by fibers; and (iv) activation of macrophages that phagocytosed the fibers. We will briefly review the translocation and biopersistence of fibers. Thereafter, we will provide an in‐depth discussion of the differences between carbon nanotubes and asbestos fibers in the mechanism of mesothelial or epithelial cell injury, with an emphasis on the cellular entry mechanism of these fibers. We will also compare the effects of carbon nanotubes and asbestos fibers on macrophage activation.

Translocation and Biopersistence of Fibers

Based on clinical observations, malignant mesothelioma develops most frequently at the parietal pleura, which unlike the visceral pleura, is not directly adjacent to the lung parenchyma. Appearance at the parietal pleura is reflected in the clinical stage. Such findings suggest that asbestos fibers somehow migrate through the lung parenchyma and reach the pleural cavity, where they come into contact with the parietal pleura. The exact mechanism by which fibers finally reach the parietal pleural has yet to be confirmed; however, Miserocchi et al.10 suggested that fibers in alveolar space travel physically through the paracellular pathway to reach the interstitial space between the lung parenchyma and visceral pleura. Then, the fibers are able to translocate to almost all organs via fluid flow, such as lymph and blood. Finally, some fibers get stuck in the parietal pleura, especially around the openings of the lymphatic stomata. An alternate hypothesis is that fibers directly translocate through the lung parenchyma and visceral pleura to reach the parietal mesothelium.11 Although the high physical resistance of the visceral pleura is difficult for any fiber to migrate through, it can still take place during chronic inflammation. During inflammation, the interstitial space exerts higher pressure, making it is easier for fibers to pass through the visceral pleura.10 Regardless of whether the fibers travel through the vascular system or directly translocate, they will be cleared by the lymphatic stomata when they reach the pleural cavity, and this pathway may partially explain why longer fibers (>8 μm), which are more likely to be trapped around the stomata compared to shorter fibers, are more carcinogenic in vivo.3, 12

The translocation of inhaled carbon nanotubes to subpleural tissue has been reported.13 The nanotubes used were suspended in phosphate‐buffered saline containing pluronic F‐68. As will be discussed later, the surface characteristics and size of nanotubes greatly affect their behavior. For example, carbon nanotubes that were covalently bonded with amino groups were easily distributed to each organ and ultimately excreted in the urine.14 This type of modification is called functionalization and is often performed to relieve the strong hydrophobicity of carbon nanotubes. The type of functional groups present on the surface of carbon nanotubes controls their hydrophilic/hydrophobic properties, which play important roles in the translocation, distribution and excretion of carbon nanotubes inside organisms. While this variable property of carbon nanotubes and its influence on cells is of interest, the biological behavior and effects of functionalized nanotubes should be carefully differentiated from those of pristine, or non‐functionalized nanotubes, which are the ones that are industrially produced, commercially distributed and of toxicological concerns. Despite the fact that functionalized nanotubes show little toxicity, it is currently unrealistic to functionalize high amounts of pristine nanotubes. Therefore, it is essential to carefully consider how pristine nanotubes would behave inside organisms for the toxicological assessment of carbon nanotubes.

Biopersistence is defined as the durability of materials inside organisms and is known to affect fiber translocation. Highly biopersistent fibers contribute to sustained inflammation and cell injury followed by the development of cancer.15 Clearance of fibers is affected by the dimension of the fiber, as long fibers that fail to be phagocytosed by macrophages are not carried and excreted.3 Furthermore, as mentioned above, long fibers are likely to be trapped at lymphatic stomata, leading to a failure of fiber clearance.12 In addition to the fiber dimension, the chemical composition of asbestos and carbon nanotubes renders them chemically stable, which enhances biopersistence because biodegradable fibers would be diminished following macrophage digestion. Mutlu et al.16 showed that carbon nanotubes that were well dispersed in pluronic solution were gradually cleared from the mouse lung. However, the translocation and biopersistence of “pristine” carbon nanotubes that are not coated by modifying materials should be investigated to gain further understanding of the toxicological property of carbon nanotubes.

Mesothelial and Epithelial Cell Injury Induced by Fibrous Materials

The carcinogenic feature of asbestos fibers and carbon nanotubes has gained a great deal of attention from both scientists and the public. Fibrous materials have the potential to transform normal cells, constituting a well‐organized tissue, into cancer cells by causing chromosomal aberrations and/or gene mutations that lead to invasion and destruction of the surrounding tissue. The target cells in fibrous material‐induced carcinogenesis are mesothelial cells or epithelial cells, but not macrophages. Therefore, the mechanism by which the DNA of mesothelial/epithelial cells is damaged has been of great interest. Currently, there are four key phenomena by which fibrous materials are postulated to cause DNA damage: (i) free radical generation on the surface; (ii) physical interaction between DNA and fibrous materials; (iii) molecule adsorption on the material surface; and (iv) chronic inflammation, as previously described.4 All of these mechanisms might take place simultaneously during fibrous material‐induced carcinogenesis, but the relative contribution of each may differ between carbon nanotubes and asbestos fibers. For example, carbon nanotubes piercing through the cellular and nuclear membrane might be more likely to directly associate with chromosomes than endocytosed asbestos fibers because penetrating carbon nanotubes are not covered by a membrane structure that would separate materials from the nuclear components (Fig. 1), as discussed previously.17

Figure 1.

Figure 1

Distinct uptake mechanism of asbestos fibers and carbon nanotubes by mesothelial cells. Chrysotile asbestos fibers (red arrows) are taken up by a mesothelial cell. Surrounding membranous structure around asbestos (blue arrowheads) indicates that the asbestos is endocytosed. On the other hand, a carbon nanotube (red arrows; diameter = ~50 nm) directly pierces the cellular and nuclear membrane. The human peritoneal mesothelial cell line was established as previously described.17 The cells were fixed after a 3 h‐incubation with indicated fibers. To increase the resolution, ultrathin sections were prepared at 80 nm thickness for asbestos. Considering the fact that carbon nanotubes are too rigid for cutting with diamond‐knife, the sections were prepared at 500 nm thickness for nanotube.

Non‐phagocytic cells, such as epithelial and mesothelial cells, form a continuous cell layer that acts as a barrier to cover and protect the underlying structure. Following exposure to fibrous materials, some of the cells undergo apoptosis or programmed necrosis, while others are able to evade such cell death mechanisms.18, 19, 20 The remaining live cells that hold these fibers inside are the most likely to become cancer cells after fibrous material‐induced DNA damage. As a consequence of DNA damage in mesothelial cells, homozygous deletion of the Cdkn2a/2b tumor suppressor genes is frequently observed, not only in asbestos‐induced mesothelioma21, 22 but also in carbon nanotube‐induced mesothelioma.17 We previously showed that mesothelioma induced by iron saccharate also displayed homozygous deletion of Cdkn2a/2b,23 suggesting that the loss of these genes might be a major event in mesothelial carcinogenesis.

Factors Involved in Carbon Nanotube and Asbestos Fiber Uptake by Non‐Phagocytic Cells

Although the exact mechanism of DNA damage is yet to be elucidated, uptake of fibrous material by non‐phagocytic cells appears an essential step in carcinogenesis. Furthermore, we believe that the key factor needed to differentiate carbon nanotube toxicology from that of asbestos fiber is the mechanism by which carbon nanotubes and asbestos fibers enter non‐phagocytic cells. As we have recently reported, carbon nanotubes directly pierce through the cell membrane to enter mesothelial cells in a diameter‐ and rigidity‐dependent manner, whereas asbestos fibers are actively endocytosed by these cells regardless of their diameter.17 This study was the first direct evidence describing the toxicological difference between carbon nanotubes and asbestos fibers regarding the mechanism of the entry of these materials into mesothelial cells. In this review, we summarize the previous literature describing how non‐phagocytic cells take up carbon nanotubes and asbestos fibers to refine and expand our understanding.

Many factors that are involved in the entry of fibrous materials into non‐phagocytic cells can be roughly divided into two categories: material characteristics and cell condition. Fibrous materials vary largely from each other in terms of their length, diameter, constituents, surface area, volume and weight. In addition to such physical variations, carbon nanotubes often contain contaminant metals because they are chemically synthesized in the presence of metal catalysts, while asbestos fibers are mined from mountains. It is also of note that the methods used to prepare suspensions of fibrous materials and the assays used for their characterization differ from lab to lab, which could account for differing results. For in vitro studies, fibrous materials are often suspended in solutions that may contain salt, proteins, DNA, polymers or alcohol, which could influence the results. Although there is a vehicle control group in cell‐based experiments, the possibility that these solvents might affect the interaction of cells with carbon nanotubes or asbestos fibers should be taken into account. Information regarding proteins or other molecules that are adsorbed onto fiber surfaces is described elsewhere and is known to affect fibrous material behavior and its effects on cells.24, 25

Cell type should also be carefully discussed in toxicology of asbestos fibers and carbon nanotubes. There are two primary cell types involved in this toxicology: non‐phagocytic cells and phagocytic cells. The interaction of each cell type with fibrous materials is important in this toxicology, but the cellular behavior and its role in pathophysiological conditions are very different.

Asbestos Fibers are Endocytosed by Mesothelial and Epithelial Cells

Because mesothelial and epithelial cells are not professional phagocytes, we should first address the question of whether asbestos fibers and carbon nanotubes enter into these cells when assessing the toxicity of these materials. The internalization of asbestos fibers into various non‐phagocytic cells has been reported by many researchers (Fig. 1). Suzuki and Jaurand et al. beautifully demonstrated that alveolar epithelial cells and pleural mesothelial cells internalized chrysotile asbestos into the phagolysosome.26, 27 Regarding the mechanism of the internalization, an interaction between the membrane proteins of the cells and proteins adsorbed onto the surface of asbestos fiber was investigated. Adsorption of vitronectin, a serum protein, onto the asbestos surface (chrysotile and crocidolite) was reported to enhance asbestos internalization by mesothelial and epithelial cells via the integrin alphaVbeta5 signaling pathways.28, 29, 30 Following the internalization of asbestos fibers into mesothelial cells, we have observed in the previous study that the asbestos fibers were surrounded by the small GTPase, Rab5a, which is a marker of the early endosome and phagosome.17, 31 Considering that the size of an endosome can be up to 1 μm,32, 33 asbestos fibers that are larger than a few microns could be internalized by a phagocytosis‐like mechanism rather than that of the endosome.

Cellular Uptake of Carbon Nanotubes Varies

Carbon nanotubes are divided into two groups depending on their structure: single‐walled carbon nanotubes (SWCNT) with a diameter of 1–3 nm and a length of 5–30 nm34 and multi‐walled carbon nanotubes (MWCNT) with a diameter of 3–200 nm and a length of tens of nanometers to microns.35, 36 As discussed previously, the size of carbon nanotubes is an important determinant of how the carbon nanotubes enter non‐phagocytic cells. Several reports have suggested that carbon nanotubes are able to enter non‐phagocytic cells via endocytosis or membrane piercing; however, a reasonable explanation on the difference has yet to be established. To identify common features of carbon nanotubes that determine the mechanism of cell entry, we have summarized the current literature describing carbon nanotube entry into non‐phagocytic cells, with a focus on length, diameter and surface functionalization of carbon nanotubes, cell type, entry mechanism and intracellular localization (Table 1).

Table 1.

Analysis of cellular entry of carbon nanotubes in non‐phagocytic cells in the literature

Nanotube Length Diameter Surface Cell type Toxicity Mechanism Intracellular location References
Endocytosis
SWCNT ~100–1000 nm 1–5 nm Covalently functionalized (oxidized) + streptavidin HL60 and Jurkat Little toxicity Endocytosis Endocytic vesicles 51
SWCNT Tens to hundreds of nm ~1.5 nm Covalently functionalized (oxidized) + streptavidin, albumin, protein A or cytochrome c HeLa, NIH3T3, HL60 and Jurkat Little toxicity Endocytosis Endocytic vesicles 50
SWCNT Short (145 nm) and long (1250 nm) 0.7–1.3 nm in ref. Non‐covalent binding with Pluronic F127 HeLa ND Endocytosis Perinuclear localization 63
MWCNT 7000–10 000 nm 80–130 nm Non‐functionalized and suspended in PBS containing 0.1% gelatin MESO‐1, BEAS‐2B and IMR‐32 Toxicity dependent on cell type Endocytosis Perinuclear localization without nuclear import 44
SWCNT ND 1 nm in ref. Non‐covalent binding with DNA NIH3T3 Little toxicity Endocytosis and exocytosis Endocytic vesicles including lysosomes 64
SWCNT ~150 nm ~1.2 nm Non‐covalent binding with DNA or phospholipid‐conjugated folic acid HeLa Selective toxicity by coupling near infrared light and interaction of folic acid‐nanotube and folate receptor‐expressing cancer cells Folate receptor‐mediated endocytosis ND 40
SWCNT 100–200 nm 1–3 nm Covalently functionalized (oxidized) + chitosan, Alexa Fluor 488 and folic acid HepG2 Little toxic up to 0.05 mg/mL Folate receptor‐mediated endocytosis Cytoplasm 42
SWCNT 100–300 nm 1–5 nm Covalently functionalized (amino group, cisplatin and folic acid) KB, JAR and Ntera‐2 Selective toxicity by coupling cisplatin and interaction of folic acid‐nanotube and folate receptor‐expressing cancer cells Folate receptor‐mediated endocytosis Endosomes 39
SWCNT 50–100 nm 1–3 nm Covalently functionalized (folic acid and Alexa Fluor 488) HepG2 Selective toxicity by coupling near infrared light and interaction of folic acid‐nanotube and folate receptor‐expressing cancer cells Folate receptor‐mediated endocytosis Cytoplasm 41
SWCNT and MWCNT SWCNT (50–200 nm) and MWCNT (500–2000 nm) SWCNT (1–3 nm) and MWCNT (10–30 nm) Covalently functionalized (oxidized) + chitosan, Alexa Fluor 488 and folic acid HepG2 Little toxic up to 0.01 mg/mL (as shown in Supporting information of reference 38) Both of endocytosis and piercing/diffusion happened. Addition of folic acid on MWCNTs enabled them to enter the cells via receptor‐mediated endocytosis Size‐dependent subcellular localization 38
SWCNT 300–1000 nm 1–5 nm Non‐covalent binding with PEG. EGF or folic acid was conjugated with PEG SKOV‐3 and OVCA 433 ND Intact but not fragmented PEG blocked non‐specific uptake of nanotubes; conjugation of EGF or folic acid promoted specific cellular uptake ND 65

MWCNT

(bamboo

structure)

3000–

10 000 nm

50–300 nm Non‐functionalized and suspended in culture medium Human epidermal keratinocytes ND Lectin receptor‐mediated pathway may be involved in cellular uptake ND 66
SWCNT 500–2000 nm 1.4 nm (10–40 nm after functionalization) Non‐covalent binding with streptavidin‐labeled quantum dot and biotinylated anti CD3 antibody Jurkat ND Endocytosis dependent on the interaction of CD3 antigen and its antibody Endocytic vesicles and not found in a nucleus 67
SWCNT 110 nm 10 nm Covalently functionalized (oxidized, EGF, Qdot and/or cisplatin) HN12, HN13, SAA and NIH3T3 Selective toxicity dependent on EGFR expression EGF and EGF receptor‐dependent endocytosis Perinuclear region 49
SWCNT <500 nm 1–2 nm Covalently functionalized (oxidized) + acridine orange HeLa Little toxicity Clathrin‐mediated endocytosis Lysosomes 68
SWCNT Short (50–200 nm) or long (200–2000 nm) Small (1–5 nm) or large (3–15 nm) Covalently functionalized (oxidized) + streptavidin or albumin, or non‐covalent binding with DNA HeLa and HL60 ND Clathrin‐mediated endocytosis ND 52
MWCNT 100–10 000 nm 10–15 nm Covalently functionalized (oxidized) + human serum albumin labeled with FITC HepG2 and CRL‐4020 Selective toxicity by coupling near infrared light and interaction of albumin and gp60‐expressing hepatic cancer cells Endocysosis; co‐localization with Gp60 (albumin‐binding protein) and caveolin‐1 Perinuclear localization (as shown in figure) 46
MWCNT 10 000–30 000 nm 20–30 nm With or without covalent functionalization. Nanotubes were dispersed in culture medium containing BSA and DPPC BEAS‐2B Induction of IL‐1β ND (Little uptake of carboxylated nanotubes; nanotubes coated with BSA and DPPC were taken up by the cells whereas non‐coated ones were not) Vesicles 43
MWCNT 10 000–40 000 nm 50–200 nm (DNA surrounding nanotubes) Non‐covalent binding with DNA separately labeled with Cy3 or folate KB No significant cell death observed up to 4 days incubation ND (Possibly via endocytosis because folate‐folate receptor interaction facilitates nanotube uptake) ND 69
SWCNT 100–400 nm 0.7–32 nm Non‐covalent binding with 29‐amino acid peptide, folding into an amphiphilic alpha‐helix and suspended in culture medium HeLa Little toxicity Time‐ and temperature‐dependent fasion (possibly endocytosis) Cytoplasm 70
SWCNT 100–400 nm 5–20 nm Non‐functionalized and suspended in culture medium HeLa Little toxicity Temperature‐dependent mechanism (possibly endocytosis) Cytoplasmic vacuoles 71
SWCNT 130–660 nm ND Non‐covalent binding with DNA NIH3T3 ND Size‐dependent uptake of nanotubes; hypothesized as receptor‐mediated endocytosis ND 37
MWCNT 7000–10 000 nm 80–130 nm Non‐functionalized and suspended in PBS containing 0.1% gelatin, 0.1% CMC or DPPC MESO‐1 and BEAS‐2B Toxicity dependent on dispersant. IL‐6 and IL‐8 production upon nanotube internalization Nanotubes dispersed in gelatin or DPPC were internalized possibly via endocytosis but nanotubes in CMC were not ND 45
SWCNT Several microns 0.7–2.1 nm Covalently functionalized (amino group) + plasmid DNA MCF‐7 Little toxicity Hypothesized as endocytosis without experimental evidence ND 72
Piercing and diffusion
SWCNT 300–1000 nm ~1 nm Covalently functionalized (amino group + peptide of alpha subunit of Gs protein) 3T6 and 3T3 Little toxic up to 10 μM Piercing and diffusion Cytoplasm and nucleus 54
SWCNT 400 nm ~1.4 nm Non‐covalent binding with RNA MCF‐7 Little toxic up to 0.5 mg/mL Piercing and diffusion Cytoplasm and nucleus 73
MWCNT 200 nm 20 nm Covalently functionalized (amino group) + plasmid DNA HeLa and CHO Little toxic up to 1.2 mg/mL Piercing and diffusion Cytoplasm and nucleus 55
SWCNT ND (commercial) ND (commercial) Covalently functionalized (amino group or FITC) Primary murine immune cells: B cells and T cells Little toxicity Piercing and diffusion Cytoplasm 53

SWCNT

and

MWCNT

SWCNT (300–1000 nm) and MWCNT (500–2000 nm) SWCNT (1 nm) and MWCNT (20–30 nm) Covalently functionalized (amino group, acetamido group, FITC, methotrexate and/or amphotericin B) 3T6, 3T3, HeLa, Jurkat, keratinocytes, A549, CHO, HEK293 and MOD‐K ND Piercing and diffusion, irrespective of functional groups and cell types Perinuclear region 56
SWCNT Length‐fractionated samples (84–411 nm) ND (commercial) Non‐covalent binding with DNA A549, MC3T3‐E1, A10 and IMR90 Toxicity dependent on length: nanotubes shorter than 189 ± 17 nm are toxic SWCNTs shorter than 189 ± 17 nm enter cells by piercing and diffusion Cytoplasm 74
MWCNT Sample 1 (~2000 nm) and sample 2 (~300 nm) Sample 1 (20–40 nm) and sample 2 (>35–40 nm) Non‐covalent binding with Pluronic F127 and suspended in cell culture medium HN9.10e (immortalized mouse hippocampal cells) and PC12 ND Piercing and diffusion, judging from the fact that sodium azide and low temperature did not hinder cellular uptake Cytoplasmic vacuoles 75
MWCNT ~1000 nm 20–30 nm Covalently functionalized (oxidized or amino group) + FITC‐BSA HEK293 ND Nanotube clusters were taken up by cells via endocytosis and individual ones via piercing and diffusion. Intracellular nanotubes were relatively short Cytoplasm, vesicles and nucleus 76
MWCNT 50–500 nm 20–30 nm Covalently functionalized (oxidized followed by introduction of amino groups) and labeled with FITC via π stacking Catharanthus roseus cell (plant cell) Little toxicity Piercing and diffusion (the average lengths of MWCNTs in cells were around 100 nm) Cytoplasm, vacuole, plastids and nucleus 77

SWCNT

and

MWCNT

SWCNT (~100 nm) and MWCNT (1000–2000 nm) SWCNT (4–5 nm in bundle) and MWCNT (20–30 nm) SWCNT: Covalently functionalized (oxidized) and labeled with FITC via π stacking Catharanthus roseus cell (plant cell) Little toxicity Piercing and diffusion into cytoplasm and active transport into vacuole Cytoplasm and nucleus 78
MWCNT 1000–2000 nm 10–30 nm ND A549 ND Piercing and diffusion (no negation of endocytic pathway) Cytoplasm and vesicles. Not found in a nucleus 79

SWCNT

and

MWCNT

SWCNT (50–500 nm) and MWCNT (50–500 nm) SWCNT (0.5–1.5 nm) and MWCNT (10–30 nm) Non‐covalent binding with phospholipid polyethylene glycol amine OVCAR8 Little toxicity Hypothesized as piercing and diffusion without experimental evidence Cytoplasm 80
MWCNT Largely up to 10 000 nm Tangled (12 nm), thin (50 nm) and thick (150 nm) Non‐functionalized and suspended in saline containing 0.5% albumin Human peritoneal mesothelial cells, MeT5A and MDCKII Diameter‐ and rigidity‐dependent toxicity and carcinogenicity: thin and rigid nanotubes were the most toxic and carcinogenic Piercing and diffusion in a diameter‐ and rigidity‐dependent manner Cytoplasm and nucleus 17
Entrance mechanism not specified or no evidence of nanotube entry
SWCNT ND (commercial), but highly aggregated 0.8–1.2 nm Non‐functionalized and suspended in culture medium A549 Low acute toxicity (0.015–0.8 mg/mL) No evidence of SWCNT internalization but ultrastructural changes in the cell morphology were observed No cellular internalization 81
MWCNT 100–13 000 nm 12 nm Non‐functionalized and suspended in dipalmitoyl lecithin, PBS or ethanol A549 and MeT5A Decrease in metabolic activity without apoptosis Small indivicdual nanotubes could be internalized but not observed with light or transmission electron microscopy No cellular internalization 82
MWCNT (bamboo structure) ND (50 000 nm when synthesized) 100 nm (bamboo structure made the thip thinner) Non‐functionalized and suspended in culture medium Human epidermal keratinocytes Slightly toxic with an induction of IL‐8 release ND (most nanotubes inside cells are <1 μm in length as shown in the figures with a maximal length of 3.6 μm) Cytoplasmic vacuoles 83
MWCNT ND ND Covalently functionalized (methotrexate and FITC) Jurkat ND ND (independent from the type of covalently‐conjugated functional groups) Perinuclear region 84
MWCNT 10 000–20 000 nm 100–150 nm Non‐functionalized and suspended in PBS containing 0.1% gelatin BEAS‐2B LDH release with IL‐6 and IL‐8 secretion ND Perinuclear localization 85
MWCNT 300–1000 nm 1 nm Covalently functionalized (amino group) A549 and CHO Little toxicity ND Perinuclear localization 86
MWCNT 500–2000 nm 20–30 nm Covalently functionalized (amino group, FITC and/or carboxy group) A549 ND (Possibly little toxicity) Both of piercing/diffusion and endocytotic pathway; predominant piercing in the precense of endocytosis inhibitors Perinuclear localization, cytoplasm and vesicles 87
MWCNT ND (500–2000 nm in ref.) 20–30 nm Covalently functionalized (dendron: alkylated amino groups) + siRNA HeLa and A549 Little toxic up to 0.08 mg/mL ND Perinuclear localization and cytoplasm 88
MWCNT Short (100–3500 nm) or long (100–12 000 nm) 10–160 nm Non‐functionalized and suspended in water containing arabic gum A549 Toxic and induces cell death ND (smallest nanotubes with a maximal length of 3 μm were internalized: 500 nm in length and 50 nm in diameter as shown in the figure) Cytoplasm and vesicles; not found in a nucleus 89
MWCNT ND (commercial) ND (commercial) Covalently functionalized (anti‐MUC‐1 aptamer was conjugated following oxidation) MCF‐7 and Calu‐6 Little toxicity ND (nanotubes were taken up by cells irrespective of MUC‐1 expression, indicating that the translocation was receptor‐independent) Cytoplasm and nucleus (as shown in the figure) 90
MWCNT 900 nm ND (<30 nm, judging from the thickness of TEM section) Non‐covalent binding with Pluronic F127 PC3 and RENCA (a murine renal cancer cell line) Selective toxicity by coupling near infrared light ND Cytoplasmic vesicle and nucleus 91
MWCNT ND (commercial) ND (commercial) Covalently functionalized (oxidized) HepG2 ND ND Cytoplasm 92
SWCNT 200–400 nm 3.8–7.8 nm in ref. Non‐covalent binding with PEG; conjugated with CpG GL261 Little toxicity ND Cytoplasm 93

SWCNT

and

MWCNT

SWCNT (5000–30 000 nm) and MWCNT (10 000–30 000 nm) SWCNT (1–2 nm) and MWCNT (20–30 nm) Non‐functionalized and suspended in PBS containing Tween 80 A3, MSTO‐211H and HaCaT SWCNTs were more toxic than MWCNTs ND (SWCNT penetrating lymphocyte cell membrane is shown in the figure) ND 94
MWCNT 1000–13 500 nm 67 nm Non‐covalent binding with Pluronic F68 BEAS‐2B and CHO‐K1 Toxicity dependent on cell density; various cytokine production ND (No differentiation between engulfed or membrane‐bound MWCNT) ND 57
MWCNT 300 nm 30–40 nm Covalently functionalized (polyamidoamine) + DNA HeLa and COS‐7 Low cytotoxicity at low concentration; positive charge of PAA‐g‐MWCNTs may contribute to the cytotoxicity ND (Labeled DNA was localized in perinuclear region) ND 95

BSA, bovine serum albumin; CMC, carboxymethyl cellulose; DPPC, dipalmytoilphosphatidylcholine; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; FITC, fluorescein isothiocyanate; IL, interleukin; in ref, described in the reference(s); LDH, lactate dehydrogenase; MWCNT, multi‐walled carbon nanotubes; ND, not described; PBS, phophate‐buffered saline; PEG, polyethylene glycol; siRNA, small interfering RNA; SWCNT, single‐walled carbon nanotube.

Size and Surface Characteristics of Carbon Nanotubes Determine Uptake Pathways

Size‐dependent uptake of carbon nanotubes into cells has been well studied.17, 37, 38 Kang et al.38 showed that SWCNTs, but not MWCNTs, all of which were oxidized and non‐covalently bound with chitosan, mainly entered human HepG2 hepatocellular carcinoma cells via endocytosis. This result indicates that large carbon nanotubes cannot be taken up by cells through endocytosis due to size limitations. However, it is notable that the conjugation of folic acid on MWCNTs enabled them to enter cells, indicating that specific, receptor‐mediated endocytosis allows large fibers to be internalized.38, 39, 40, 41, 42 We recently showed that MWCNTs coated with albumin on their surface were not endocytosed by two different human mesothelial cell lines.17 Instead, we found that these MWCNTs directly pierced through the plasma and nuclear membranes in a diameter‐ and rigidity‐dependent manner, suggesting that large MWCNTs can still enter cells through direct piercing rather than endocytosis. On the other hand, Wang et al.43 showed that MWCNTs coated with both albumin and phospholipid (DPPC, dipalmitoyl‐phosphatidylcholine) were successfully internalized by bronchial epithelial BEAS‐2B cells. Moreover, Haniu et al.44, 45 showed that MWCNTs bound to gelatin or a phospholipid (DPPC) were taken up by mesothelioma MESO‐1 cells, bronchial epithelial BEAS‐2B cells and neuroblastoma IMR‐32 cells. Taken together, current data indicate that MWCNTs, which are comparatively larger than endosomes, may not be endocytosed, but the presence of specific molecules, such as folic acid and DPPC, may help cells take up MWCNTs. Albumin did not facilitate endocytosis in our previous study, but previous reports indicate that albumin may help endocytosis if the target cells express high levels of an albumin receptor, such as gp60.46 Similarly, Jin et al.37 showed that among small SWCNTs, the efficiency of nanotube uptake is also size‐dependent. They showed that SWCNTs wrapped by DNA were most efficiently taken up by NIH3T3 cells when the nanotube length was ~300 nm.

Regarding the size limitation on membrane piercing, it is of note that Kusumi and colleagues reported a membrane skeleton fence model.47, 48 This model explains that an actin mesh network exists just beneath the cell membrane to form compartments whose size are dependent on cell type (side length is 30–230 nm). Based on this model, we can expect that very thick nanotubes (>230 nm) that evade endocytosis due to their surface property cannot directly pierce the membrane.

Surface characteristics are also critical in carbon nanotube uptake. For instance, oxidized nanotubes are more likely to enter cells via endocytosis with the help of specific ligands42, 46, 49, 50, 51, 52 because the oxidation of nanotubes introduces carboxyl groups, which provides a negative charge to their surface, resulting in repulsion from the plasma membrane unless the carbon nanotube has ligands that are recognized with a high affinity by the cell. Many ligands (folic acid,42 albumin46 and epidermal growth factor49) have been reported to facilitate uptake by specific cell types. Alternatively, a carbon nanotube with amino groups presents a positive charge on its surface and can enter cells via energy‐independent piercing and diffusion.53, 54, 55 On the other hand, Kostarelos et al.56 showed that MWCNTs with functional groups entered various types of cells in a functional group‐independent manner via membrane piercing and diffusion. In our own studies we have found that pristine MWCNTs with albumin on their surface pierced the cell membrane in a diameter‐dependent manner.17 These results indicate that a positive charge on the surface of carbon nanotubes might not be necessary for the carbon nanotubes to pierce through the cell membrane. However, the detailed mechanism remains to be elucidated.

Carbon Nanotubes and Asbestos Fibers Activate Macrophages

Macrophages are a type of immune cell that function in the recognition and removal of pathogens and exogenous materials. Macrophages sometimes fail to achieve this goal when the pathogens are too large and/or resistant to biodegradation. Certain nanotubes and asbestos fibers have these features, leading to persistent macrophage activation and enhanced chronic inflammation.5, 6

It has been reported that macrophages recognize asbestos fibers and carbon nanotubes via the class A scavenger receptor, MARCO (macrophage receptor with collagenous structure).57, 58, 59, 60 Moreover, the uptake of these two types of materials activates the NLRP3 inflammasome.61, 62 Therefore, asbestos fibers and carbon nanotubes appear to activate macrophages through similar mechanisms. It is noteworthy that the carbon nanotubes used in these experiments were non‐functionalized.

Concluding Remarks

A number of sequential events are involved in fibrous material (i.e. carbon nanotubes and asbestos fibers) toxicology: translocation of materials, biopersistence of materials, mesothelial/epithelial cell injury induced by materials and macrophage activation triggered by materials. Among these, we focused on how asbestos fibers and carbon nanotubes enter non‐phagocytic cells, which is important in mesothelial/epithelial cell injury.96, 97 Asbestos fibers are endocytosed by these non‐phagocytic cells and carbon nanotubes behave variably according to their functionalization and size (Fig. 2). Based on current evidence, a positive charge on the surface and a thin diameter appear to be two important factors in facilitating the membrane piercing ability of carbon nanotubes. The presence of specific ligands on the carbon nanotube surface would induce ligand‐mediated endocytosis, which allows large‐sized nanotubes to enter non‐phagocytic cells. Further investigation regarding the mechanism of entry of carbon nanotubes and asbestos fibers into non‐phagocytic cells is warranted to establish the distinct toxicological paradigms of carbon nanotubes and asbestos fibers.

Figure 2.

Figure 2

A schematic of the fiber entry mechanism into a non‐phagocytic cell. Asbestos fibers are endocytosed by the cells through phagocytosis‐like mechanisms. Mechanisms of carbon nanotube uptake depend on the characteristics of each fiber. Nanotubes with thin diameter (~50 nm in Fig. 1), high rigidity and positive surface charge are likely to pierce the plasma and nuclear membrane whereas nanotubes with shorter length (<1 μm) and specific ligands on their surface with modification would be endocytosed by the cells.

Disclosure Statement

The authors have no conflict of interest.

Acknowledgments

We thank Shan Hwu Chew (Nagoya University) for her critical comments and suggestions on the manuscript. This study was supported by Princess Takamatsu Cancer Research Fund Grant 10‐24213; grant‐in‐aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan; a grant‐in‐aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a MEXT Special Coordination Funds for Promoting Science and Technology Grant; a grant from the Takeda Science Foundation; and a grant‐in‐aid from the Japan Society for the Promotion of Science Fellows (HN).

References

  • 1. Thayer AM. Carbon nanotubes by the metric ton. Chem Eng News 2007; 85: 29–35. [Google Scholar]
  • 2. Toyokuni S. Mechanisms of asbestos‐induced carcinogenesis. Nagoya J Med Sci 2009; 71: 1–10. [PMC free article] [PubMed] [Google Scholar]
  • 3. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010; 7: 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Nagai H, Toyokuni S. Biopersistent fiber‐induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys 2010; 502: 1–7. [DOI] [PubMed] [Google Scholar]
  • 5. Poland CA, Duffin R, Kinloch I et al Carbon nanotubes introduced into the abdominal cavity of mice show asbestos‐like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423–8. [DOI] [PubMed] [Google Scholar]
  • 6. Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. Inflammation generating potential of long and short fibre amosite asbestos samples. Br J Ind Med 1989; 46: 271–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Oberdorster G. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol 2002; 14: 29–56. [DOI] [PubMed] [Google Scholar]
  • 8. Brown DM, Kinloch IA, Bangert U et al An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 2007; 45: 1743–56. [Google Scholar]
  • 9. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 2009; 4: 627–33. [DOI] [PubMed] [Google Scholar]
  • 10. Miserocchi G, Sancini G, Mantegazza F, Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ Health 2008; 7: 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Murphy FA, Poland CA, Duffin R et al Length‐dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011; 178: 2587–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Moalli PA, MacDonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol 1987; 128: 426–45. [PMC free article] [PubMed] [Google Scholar]
  • 13. Ryman‐Rasmussen JP, Cesta MF, Brody AR et al Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 2009; 4: 747–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Singh R, Pantarotto D, Lacerda L et al Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Hesterberg TW, Chase G, Axten C et al Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 1998; 151: 262–75. [DOI] [PubMed] [Google Scholar]
  • 16. Mutlu GM, Budinger GR, Green AA et al Biocompatible nanoscale dispersion of single‐walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett 2010; 10: 1664–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Nagai H, Okazaki Y, Chew SH et al Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci USA 2011; 108: E1330–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Liu W, Ernst JD, Broaddus VC. Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol 2000; 23: 371–8. [DOI] [PubMed] [Google Scholar]
  • 19. Shukla A, Stern M, Lounsbury KM, Flanders T, Mossman BT. Asbestos‐induced apoptosis is protein kinase C delta‐dependent. Am J Respir Cell Mol Biol 2003; 29: 198–205. [DOI] [PubMed] [Google Scholar]
  • 20. Yang H, Rivera Z, Jube S et al Programmed necrosis induced by asbestos in human mesothelial cells causes high‐mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010; 107: 12611–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Altomare DA, Vaslet CA, Skele KL et al A mouse model recapitulating molecular features of human mesothelioma. Cancer Res 2005; 65: 8090–5. [DOI] [PubMed] [Google Scholar]
  • 22. Jean D, Thomas E, Manie E et al Syntenic relationships between genomic profiles of fiber‐induced murine and human malignant mesothelioma. Am J Pathol 2011; 178: 881–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hu Q, Akatsuka S, Yamashita Y et al Homozygous deletion of CDKN2A/2B is a hallmark of iron‐induced high‐grade rat mesothelioma. Lab Invest 2010; 90: 360–73. [DOI] [PubMed] [Google Scholar]
  • 24. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008; 105: 14265–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. MacCorkle RA, Slattery SD, Nash DR, Brinkley BR. Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts. Cell Motil Cytoskeleton 2006; 63: 646–57. [DOI] [PubMed] [Google Scholar]
  • 26. Suzuki Y. Interaction of asbestos with alveolar cells. Environ Health Perspect 1974; 9: 241–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Jaurand MC, Kaplan H, Thiollet J, Pinchon MC, Bernaudin JF, Bignon J. Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol 1979; 94: 529–38. [PMC free article] [PubMed] [Google Scholar]
  • 28. Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 1995; 96: 1987–2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Wu J, Liu W, Koenig K, Idell S, Broaddus VC. Vitronectin adsorption to chrysotile asbestos increases fiber phagocytosis and toxicity for mesothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L916–23. [DOI] [PubMed] [Google Scholar]
  • 30. Pande P, Mosleh TA, Aust AE. Role of alphavbeta5 integrin receptor in endocytosis of crocidolite and its effect on intracellular glutathione levels in human lung epithelial (A549) cells. Toxicol Appl Pharmacol 2006; 210: 70–7. [DOI] [PubMed] [Google Scholar]
  • 31. Henry RM, Hoppe AD, Joshi N, Swanson JA. The uniformity of phagosome maturation in macrophages. J Cell Biol 2004; 164: 185–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Ganley IG, Carroll K, Bittova L, Pfeffer S. Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Mol Biol Cell 2004; 15: 5420–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size‐dependent internalization of particles via the pathways of clathrin‐ and caveolae‐mediated endocytosis. Biochem J 2004; 377: 159–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Jorio A, Saito R, Hafner JH et al Structural (n, m) determination of isolated single‐wall carbon nanotubes by resonant Raman scattering. Phys Rev Lett 2001; 86: 1118–21. [DOI] [PubMed] [Google Scholar]
  • 35. Endo M, Kroto HW. Formation of carbon nanofibers. J Phys Chem 1992; 96: 6941–4. [Google Scholar]
  • 36. Donaldson K, Aitken R, Tran L et al Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006; 92: 5–22. [DOI] [PubMed] [Google Scholar]
  • 37. Jin H, Heller DA, Sharma R, Strano MS. Size‐dependent cellular uptake and expulsion of single‐walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 2009; 3: 149–58. [DOI] [PubMed] [Google Scholar]
  • 38. Kang B, Chang S, Dai Y, Yu D, Chen D. Cell response to carbon nanotubes: size‐dependent intracellular uptake mechanism and subcellular fate. Small 2010; 6: 2362–6. [DOI] [PubMed] [Google Scholar]
  • 39. Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. Targeted single‐wall carbon nanotube‐mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc 2008; 130: 11467–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near‐infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005; 102: 11600–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Kang B, Yu D, Dai Y, Chang S, Chen D, Ding Y. Cancer‐cell targeting and photoacoustic therapy using carbon nanotubes as “bomb” agents. Small 2009; 5: 1292–301. [DOI] [PubMed] [Google Scholar]
  • 42. Kang B, Yu DC, Chang SQ, Chen D, Dai YD, Ding Y. Intracellular uptake, trafficking and subcellular distribution of folate conjugated single walled carbon nanotubes within living cells. Nanotechnology 2008; 19: 375103. [DOI] [PubMed] [Google Scholar]
  • 43. Wang X, Xia T, Ntim SA et al Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano 2011; 5: 9772–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Haniu H, Saito N, Matsuda Y et al Elucidation mechanism of different biological responses to multi‐walled carbon nanotubes using four cell lines. Int J Nanomedicine 2011; 6: 3487–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Haniu H, Saito N, Matsuda Y et al Effect of dispersants of multi‐walled carbon nanotubes on cellular uptake and biological responses. Int J Nanomedicine 2011; 6: 3295–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Iancu C, Mocan L, Bele C et al Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin. Int J Nanomedicine 2011; 6: 129–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Morone N, Fujiwara T, Murase K et al Three‐dimensional reconstruction of the membrane skeleton at the plasma membrane interface by electron tomography. J Cell Biol 2006; 174: 851–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Ritchie K, Iino R, Fujiwara T, Murase K, Kusumi A. The fence and picket structure of the plasma membrane of live cells as revealed by single molecule techniques (review). Mol Membr Biol 2003; 20: 13–8. [DOI] [PubMed] [Google Scholar]
  • 49. Bhirde AA, Patel V, Gavard J et al Targeted killing of cancer cells in vivo and in vitro with EGF‐directed carbon nanotube‐based drug delivery. ACS Nano 2009; 3: 307–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Kam NW, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 2005; 127: 6021–6. [DOI] [PubMed] [Google Scholar]
  • 51. Kam NW, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005; 127: 12492–3. [DOI] [PubMed] [Google Scholar]
  • 52. Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl 2006; 45: 577–81. [DOI] [PubMed] [Google Scholar]
  • 53. Dumortier H, Lacotte S, Pastorin G et al Functionalized carbon nanotubes are non‐cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006; 6: 1522–8. [DOI] [PubMed] [Google Scholar]
  • 54. Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chemical Commun 2004; 7: 16–7. [DOI] [PubMed] [Google Scholar]
  • 55. Pantarotto D, Singh R, McCarthy D et al Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed Engl 2004; 43: 5242–6. [DOI] [PubMed] [Google Scholar]
  • 56. Kostarelos K, Lacerda L, Pastorin G et al Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol 2007; 2: 108–13. [DOI] [PubMed] [Google Scholar]
  • 57. Hirano S, Fujitani Y, Furuyama A, Kanno S. Macrophage receptor with collagenous structure (MARCO) is a dynamic adhesive molecule that enhances uptake of carbon nanotubes by CHO‐K1 cells. Toxicol Appl Pharmacol 2011; 259: 96–103. [DOI] [PubMed] [Google Scholar]
  • 58. Hirano S, Kanno S, Furuyama A. Multi‐walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 2008; 232: 244–51. [DOI] [PubMed] [Google Scholar]
  • 59. Krieger M, Stern DM. Series introduction: multiligand receptors and human disease. J Clin Invest 2001; 108: 645–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Resnick D, Freedman NJ, Xu S, Krieger M. Secreted extracellular domains of macrophage scavenger receptors form elongated trimers which specifically bind crocidolite asbestos. J Biol Chem 1993; 268: 3538–45. [PubMed] [Google Scholar]
  • 61. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Palomaki J, Valimaki E, Sund J et al Long, needle‐like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011; 5: 6861–70. [DOI] [PubMed] [Google Scholar]
  • 63. Yaron PN, Holt BD, Short PA, Losche M, Islam MF, Dahl KN. Single wall carbon nanotubes enter cells by endocytosis and not membrane penetration. J Nanobiotechnol 2011; 9: 45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Jin H, Heller DA, Strano MS. Single‐particle tracking of endocytosis and exocytosis of single‐walled carbon nanotubes in NIH‐3T3 cells. Nano Lett 2008; 8: 1577–85. [DOI] [PubMed] [Google Scholar]
  • 65. Zeineldin R, Al‐Haik M, Hudson LG. Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells. Nano Lett 2009; 9: 751–7. [DOI] [PubMed] [Google Scholar]
  • 66. Zhang LW, Monteiro‐Riviere NA. Lectins modulate multi‐walled carbon nanotubes cellular uptake in human epidermal keratinocytes. Toxicol In Vitro 2010; 24: 546–51. [DOI] [PubMed] [Google Scholar]
  • 67. Bottini M, Cerignoli F, Dawson MI, Magrini A, Rosato N, Mustelin T. Full‐length single‐walled carbon nanotubes decorated with streptavidin‐conjugated quantum dots as multivalent intracellular fluorescent nanoprobes. Biomacromolecules 2006; 7: 2259–63. [DOI] [PubMed] [Google Scholar]
  • 68. Zhang X, Meng L, Wang X, Lu Q. Preparation and cellular uptake of pH‐dependent fluorescent single‐wall carbon nanotubes. Chemistry 2010; 16: 556–61. [DOI] [PubMed] [Google Scholar]
  • 69. Ko S, Jang J. Controlled amine functionalization on conducting polypyrrole nanotubes as effective transducers for volatile acetic acid. Biomacromolecules 2007; 8: 182–7. [DOI] [PubMed] [Google Scholar]
  • 70. Chin SF, Baughman RH, Dalton AB et al Amphiphilic helical peptide enhances the uptake of single‐walled carbon nanotubes by living cells. Exp Biol Med (Maywood) 2007; 232: 1236–44. [DOI] [PubMed] [Google Scholar]
  • 71. Yehia HN, Draper RK, Mikoryak C et al Single‐walled carbon nanotube interactions with HeLa cells. J Nanobiotechnol 2007; 5: 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Karmakar A, Bratton SM, Dervishi E et al Ethylenediamine functionalized‐single‐walled nanotube (f‐SWNT)‐assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF‐7 cells. Int J Nanomedicine 2011; 6: 1045–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Lu Q, Moore JM, Huang G et al RNA polymer translocation with single‐walled carbon nanotubes. Nano Lett 2004; 4: 2473–7. [Google Scholar]
  • 74. Becker ML, Fagan JA, Gallant ND et al Length‐dependent uptake of DNA‐wrapped single‐walled carbon nanotubes. Adv Mater 2007; 19: 939–45. [Google Scholar]
  • 75. Raffa V, Ciofani G, Nitodas S et al Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 2008; 46: 1600–10. [Google Scholar]
  • 76. Mu Q, Broughton DL, Yan B. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett 2009; 9: 4370–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Serag MF, Kaji N, Gaillard C et al Trafficking and subcellular localization of multiwalled carbon nanotubes in plant cells. ACS Nano 2011; 5: 493–9. [DOI] [PubMed] [Google Scholar]
  • 78. Serag MF, Kaji N, Venturelli E et al Functional platform for controlled subcellular distribution of carbon nanotubes. ACS Nano 2011; 5: 9264–70. [DOI] [PubMed] [Google Scholar]
  • 79. Sund J, Alenius H, Vippola M, Savolainen K, Puustinen A. Proteomic characterization of engineered nanomaterial‐protein interactions in relation to surface reactivity. ACS Nano 2011; 5: 4300–9. [DOI] [PubMed] [Google Scholar]
  • 80. Bhirde AA, Liu G, Jin A et al Combining portable Raman probes with nanotubes for theranostic applications. Theranostics 2011; 1: 310–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Davoren M, Herzog E, Casey A et al In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol In Vitro 2007; 21: 438–48. [DOI] [PubMed] [Google Scholar]
  • 82. Tabet L, Bussy C, Amara N et al Adverse effects of industrial multiwalled carbon nanotubes on human pulmonary cells. J Toxicol Environ Health A 2009; 72: 60–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Monteiro‐Riviere NA, Nemanich RJ, Inman AO, Wang YYY, Riviere JE. Multi‐walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005; 155: 377–84. [DOI] [PubMed] [Google Scholar]
  • 84. Pastorin G, Wu W, Wieckowski S et al Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun (Camb) 2006; 21: 1182–4. [DOI] [PubMed] [Google Scholar]
  • 85. Tsukahara T, Haniu H. Cellular cytotoxic response induced by highly purified multi‐wall carbon nanotube in human lung cells. Mol Cell Biochem 2011; 352: 57–63. [DOI] [PubMed] [Google Scholar]
  • 86. Lacerda L, Pastorin G, Gathercole D et al Intracellular trafficking of carbon nanotubes by confocal laser scanning microscopy. Adv Mater 2007; 19: 1480–4. [Google Scholar]
  • 87. Lacerda L, Russier J, Pastorin G et al Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 2012; 33: 3334–43. [DOI] [PubMed] [Google Scholar]
  • 88. Al‐Jamal KT, Toma FM, Yilmazer A et al Enhanced cellular internalization and gene silencing with a series of cationic dendron‐multiwalled carbon nanotube:siRNA complexes. FASEB J 2010; 24: 4354–65. [DOI] [PubMed] [Google Scholar]
  • 89. Simon‐Deckers A, Gouget B, Mayne‐L'hermite M, Herlin‐Boime N, Reynaud C, Carriere M. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 2008; 253: 137–46. [DOI] [PubMed] [Google Scholar]
  • 90. Van den Bossche J, Al‐Jamal WT, Tian B et al Efficient receptor‐independent intracellular translocation of aptamers mediated by conjugation to carbon nanotubes. Chem Commun (Camb) 2010; 46: 7379–81. [DOI] [PubMed] [Google Scholar]
  • 91. Fisher JW, Sarkar S, Buchanan CF et al Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res 2010; 70: 9855–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Romero G, Rojas E, Estrela‐Lopis I, Donath E, Moya SE. Spontaneous confocal Raman microscopy–a tool to study the uptake of nanoparticles and carbon nanotubes into cells. Nanoscale Res Lett 2011; 6: 429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Zhao D, Alizadeh D, Zhang L et al Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin Cancer Res 2011; 17: 771–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Hu X, Cook S, Wang P, Hwang HM, Liu X, Williams QL. In vitro evaluation of cytotoxicity of engineered carbon nanotubes in selected human cell lines. Sci Total Environ 2010; 408: 1812–7. [DOI] [PubMed] [Google Scholar]
  • 95. Liu M, Chen B, Xue Y et al Polyamidoamine‐grafted multiwalled carbon nanotubes for gene delivery: synthesis, transfection and intracellular trafficking. Bioconjug Chem 2011; 22: 2237–43. [DOI] [PubMed] [Google Scholar]
  • 96. Nagai H, Ishihara T, Lee WH et al Asbestos surface provides a niche for oxidative modification. Cancer Sci 2011; 102: 2118–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Jiang L, Nagai H, Ohara H et al Characteristics and modifying factors of asbestos‐induced oxidative DNA damage. Cancer Sci 2008; 99: 2142–51. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES